Overview

Study of Capecitabine in Combination With SIR-Spheres in Patients With Advanced Cancer

Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
This trial is testing the safety of combining the oral chemotherapy drug capecitabine with radio-labeled microspheres injected directly into the liver.
Phase:
Phase 1
Details
Lead Sponsor:
Fox Chase Cancer Center
Collaborator:
Sirtex Medical
Treatments:
Capecitabine